SANG CHARLES

CIK 00017806561 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780656

Recent Transactions

15 trades

Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-12-11−50,000→ 155,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-11$56.13/sh−50,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-11$6.55/sh+50,000→ 50,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-15$44.00/sh−25,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-15$6.32/sh+25,000→ 25,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-09-15−25,000→ 55,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-14$6.55/sh+25,000→ 25,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-14$42.50/sh−25,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-09-14−25,000→ 205,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-05-15−20,000→ 230,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-05-15$38.01/sh−40,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-05-15$6.55/sh+20,000→ 40,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-05-15−20,000→ 80,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-05-15$6.32/sh+20,000→ 20,000 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-02-13+40,000→ 40,000 total

Companies

Adaptive Biotechnologies Corp
Sr VP, Clinical Diagnostics
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200

SEATTLE, WA, 98102

View on SEC.gov